Copy
See below for a daily digest of the latest Parkinson's Disease news & perspectives!

Electrodes Placed in Brain May Offer Way of ‘Sensing’ Parkinson’s Arrival

Sep 16, 2020 07:00 am | Diana Campelo Delgado

 

dopamine and brain tissueEngineers with Michigan State University (MSU) are developing diamond-based electrodes that might detect early warning signs of neurodegenerative diseases such as Parkinson’s in a living brain. MSU researchers Wen Li and Erin Purcell have received $3.4 million in funding from the National Institutes of Health and an MSU Strategic Partnership Grant to conduct preclinical work evaluating the safety, durability, […]

The post Electrodes Placed in Brain May Offer Way of ‘Sensing’ Parkinson’s Arrival appeared first on Parkinson's News Today.

Read More
share on Twitter Like Electrodes Placed in Brain May Offer Way of ‘Sensing’ Parkinson’s Arrival on Facebook

Supernus Submits SPN-830 Apomorphine Infusion Pump for FDA Approval

Sep 16, 2020 07:00 am | Marisa Wexler

 

SPN-830Supernus Pharmaceuticals has submitted a new drug application to the U.S. Food and Drug Administration (FDA) seeking approval of SPN-830, its apomorphine infusion pump, the company said. If approved, the pump will be used for the continuous treatment of on-off episodes in adults with Parkinson’s disease who continue to experience motor symptoms after treatment with oral levodopa and […]

The post Supernus Submits SPN-830 Apomorphine Infusion Pump for FDA Approval appeared first on Parkinson's News Today.

Read More
share on Twitter Like Supernus Submits SPN-830 Apomorphine Infusion Pump for FDA Approval on Facebook

Kynmobi Safe, Effective for ‘Off’ Periods Over Long Term, Ongoing Trial Reports

Sep 15, 2020 07:00 am | Marisa Wexler

 

Kynmobi trial dataSunovion‘s Kynmobi (apomorphine hydrochloride), a sublingual film treatment for “off” episodes in people with Parkinson’s disease, has a manageable safety profile and maintains efficacy over up to nearly a year of use, interim data from an ongoing Phase 3 trial show. Findings were presented at MDS Virtual Congress 2020 in the study, “A Long-Term Safety, Tolerability, […]

The post Kynmobi Safe, Effective for ‘Off’ Periods Over Long Term, Ongoing Trial Reports appeared first on Parkinson's News Today.

Read More
share on Twitter Like Kynmobi Safe, Effective for ‘Off’ Periods Over Long Term, Ongoing Trial Reports on Facebook

Research Shows How PARK7 Gene Mutations Cause Early Onset Parkinson’s

Sep 15, 2020 07:00 am | Steve Bryson PhD

 

PARK7 geneMutations in the PARK7 gene, known to cause early onset Parkinson’s disease, result in low levels of a protein called DJ-1 that is essential for nerve cell health, a study revealed. In fixing a protein processing malfunction in cells derived from members of a single family who carried a particular mutation in this gene, a team […]

The post Research Shows How PARK7 Gene Mutations Cause Early Onset Parkinson’s appeared first on Parkinson's News Today.

Read More
share on Twitter Like Research Shows How PARK7 Gene Mutations Cause Early Onset Parkinson’s on Facebook



Recent Posts

4th-generation DBS System, Vercise Genus, Available in Europe
Disturbed Sleep Tied to Cognitive Problems in Parkinson’s Patients
Preventing Conductor Malfunction During a ‘Perfect Storm’
Hidrox, an Olive Extract, Eased Parkinson’s Symptoms in Mice, Study Finds
Newly Launched Valted Seq Working to Discover Disease Pathways, Biomarkers

Copyright © 2020 BioNews Services, LLC, All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences